Cell therapies for traumatic brain injury - PubMed (original) (raw)
Review
Cell therapies for traumatic brain injury
Matthew T Harting et al. Neurosurg Focus. 2008.
Abstract
Preliminary discoveries of the efficacy of cell therapy are currently being translated to clinical trials. Whereas a significant amount of work has been focused on cell therapy applications for a wide array of diseases, including cardiac disease, bone disease, hepatic disease, and cancer, there continues to be extraordinary anticipation that stem cells will advance the current therapeutic regimen for acute neurological disease. Traumatic brain injury is a devastating event for which current therapies are limited. In this report the authors discuss the current status of using adult stem cells to treat traumatic brain injury, including the basic cell types and potential mechanisms of action, preclinical data, and the initiation of clinical trials.
Figures
Fig. 1
Light microscopic image showing MSCs grown in vitro after isolation from bone marrow and several passages.
Fig. 2
Left: Light microscopic image demonstrating NSCs (arrows) grown in vitro after isolation from the subventricular zone. Right: Light microscopic image showing a magnified view of the NSCs as groups of cells called neurospheres.
Fig. 3
Protocol for enrollment, cell infusion, and follow-up in a Phase I clinical trial assessing the safety of autologous bone marrow cells in children after TBI. ARDS = acute respiratory distress syndrome; BM = bone marrow; BMT = BM transplantation; CAGT = The Center for Cell and Gene Therapy; DTMR = diffusion tensor magnetic resonance (imaging); GOS = Glascow Outcome Scale; Neuro = neuropsychiatric testing.
Similar articles
- Stem cell therapies for traumatic brain injury.
Koliatsos VE, Xu L, Cummings BJ. Koliatsos VE, et al. Regen Med. 2015 Nov;10(8):917-20. doi: 10.2217/rme.15.62. Epub 2015 Nov 6. Regen Med. 2015. PMID: 26542417 No abstract available. - Clinical translation of stem cell therapy in traumatic brain injury: the potential of encapsulated mesenchymal cell biodelivery of glucagon-like peptide-1.
Heile A, Brinker T. Heile A, et al. Dialogues Clin Neurosci. 2011;13(3):279-86. doi: 10.31887/DCNS.2011.13.2/aheile. Dialogues Clin Neurosci. 2011. PMID: 22034462 Free PMC article. Review. - Progenitor cell therapies for traumatic brain injury: barriers and opportunities in translation.
Walker PA, Shah SK, Harting MT, Cox CS Jr. Walker PA, et al. Dis Model Mech. 2009 Jan-Feb;2(1-2):23-38. doi: 10.1242/dmm.001198. Dis Model Mech. 2009. PMID: 19132123 Free PMC article. Review. - Developments in intracerebral stem cell grafts.
Reyes S, Tajiri N, Borlongan CV. Reyes S, et al. Expert Rev Neurother. 2015 Apr;15(4):381-93. doi: 10.1586/14737175.2015.1021787. Epub 2015 Mar 5. Expert Rev Neurother. 2015. PMID: 25739415 Free PMC article. Review. - Stem cell therapy for neurological disorders: A focus on aging.
Nguyen H, Zarriello S, Coats A, Nelson C, Kingsbury C, Gorsky A, Rajani M, Neal EG, Borlongan CV. Nguyen H, et al. Neurobiol Dis. 2019 Jun;126:85-104. doi: 10.1016/j.nbd.2018.09.011. Epub 2018 Sep 13. Neurobiol Dis. 2019. PMID: 30219376 Free PMC article. Review.
Cited by
- Mapping knowledge of the stem cell in traumatic brain injury: a bibliometric and visualized analysis.
Deng T, Ding R, Wang Y, Chen Y, Sun H, Zheng M. Deng T, et al. Front Neurol. 2024 Mar 8;15:1301277. doi: 10.3389/fneur.2024.1301277. eCollection 2024. Front Neurol. 2024. PMID: 38523616 Free PMC article. - Backpack-mediated anti-inflammatory macrophage cell therapy for the treatment of traumatic brain injury.
Kapate N, Liao R, Sodemann RL, Stinson T, Prakash S, Kumbhojkar N, Suja VC, Wang LL, Flanz M, Rajeev R, Villafuerte D, Shaha S, Janes M, Park KS, Dunne M, Golemb B, Hone A, Adebowale K, Clegg J, Slate A, McGuone D, Costine-Bartell B, Mitragotri S. Kapate N, et al. PNAS Nexus. 2023 Dec 13;3(1):pgad434. doi: 10.1093/pnasnexus/pgad434. eCollection 2024 Jan. PNAS Nexus. 2023. PMID: 38187808 Free PMC article. - Applying hiPSCs and Biomaterials Towards an Understanding and Treatment of Traumatic Brain Injury.
Lacalle-Aurioles M, Cassel de Camps C, Zorca CE, Beitel LK, Durcan TM. Lacalle-Aurioles M, et al. Front Cell Neurosci. 2020 Nov 12;14:594304. doi: 10.3389/fncel.2020.594304. eCollection 2020. Front Cell Neurosci. 2020. PMID: 33281561 Free PMC article. Review. - Progenitor cell therapy for acquired pediatric nervous system injury: Traumatic brain injury and acquired sensorineural hearing loss.
Baumgartner JE, Baumgartner LS, Baumgartner ME, Moore EJ, Messina SA, Seidman MD, Shook DR. Baumgartner JE, et al. Stem Cells Transl Med. 2021 Feb;10(2):164-180. doi: 10.1002/sctm.20-0026. Epub 2020 Oct 9. Stem Cells Transl Med. 2021. PMID: 33034162 Free PMC article. Review. - Evaluation of M2-like macrophage enrichment after diffuse traumatic brain injury through transient interleukin-4 expression from engineered mesenchymal stromal cells.
Enam SF, Kader SR, Bodkin N, Lyon JG, Calhoun M, Azrak C, Tiwari PM, Vanover D, Wang H, Santangelo PJ, Bellamkonda RV. Enam SF, et al. J Neuroinflammation. 2020 Jun 20;17(1):197. doi: 10.1186/s12974-020-01860-y. J Neuroinflammation. 2020. PMID: 32563258 Free PMC article.
References
- Al Nimer F, Wennersten A, Holmin S, Meijer X, Wahlberg L, Mathiesen T. MHC expression after human neural stem cell transplantation to brain contused rats. Neuroreport. 2004;15:1871–1875. - PubMed
- Anonymous: Consensus conference. Rehabilitation of persons with traumatic brain injury. NIH Consensus Development Panel on Rehabilitation of Persons With Traumatic Brain Injury. JAMA. 1999;282:974–983. - PubMed
- Bakshi A, Shimizu S, Keck CA, Cho S, LeBold DG, Morales D, et al. Neural progenitor cells engineered to secrete GDNF show enhanced survival, neuronal differentiation and improve cognitive function following traumatic brain injury. Eur J Neurosci. 2006;23:2119–2134. - PubMed
- Boockvar JA, Schouten J, Royo N, Millard M, Spangler Z, Castelbuono D, et al. Experimental traumatic brain injury modulates the survival, migration, and terminal phenotype of transplanted epidermal growth factor receptor-activated neural stem cells. Neurosurgery. 2005;56:163–171. - PubMed
- Borlongan CV, Hadman M, Sanberg CD, Sanberg PR. Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke. 2004;35:2385–2389. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical